|
C1ORF144 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.020200E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.825800E-01 |
| Normal-vs-Stage2 |
2.638800E-03 |
| Normal-vs-Stage3 |
3.213900E-02 |
| Normal-vs-Stage4 |
1.114420E-01 |
| Stage1-vs-Stage2 |
1.459690E-02 |
| Stage1-vs-Stage3 |
9.287900E-02 |
| Stage1-vs-Stage4 |
2.539800E-01 |
| Stage2-vs-Stage3 |
2.789600E-01 |
| Stage2-vs-Stage4 |
2.025200E-01 |
| Stage3-vs-Stage4 |
7.735200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.915600E-02 |
| Normal-vs-AfricanAmerican |
2.769700E-02 |
| Normal-vs-Asian |
8.460000E-01 |
| Caucasian-vs-AfricanAmerican |
1.188850E-01 |
| Caucasian-vs-Asian |
8.414000E-01 |
| AfricanAmerican-vs-Asian |
4.777800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.079770E-02 |
| Normal-vs-Female |
6.534800E-01 |
| Male-vs-Female |
3.460200E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.148000E-01 |
| Normal-vs-Age(41-60Yrs) |
4.268200E-01 |
| Normal-vs-Age(61-80Yrs) |
1.422340E-02 |
| Normal-vs-Age(81-100Yrs) |
1.220750E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.522400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.353000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.436000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.362000E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.256000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.347200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
8.858400E-03 |
| Normal-vs-Grade 2 |
7.893400E-01 |
| Normal-vs-Grade 3 |
3.995800E-04 |
| Normal-vs-Grade 4 |
1.942980E-01 |
| Grade 1-vs-Grade 2 |
3.765500E-02 |
| Grade 1-vs-Grade 3 |
7.573700E-04 |
| Grade 1-vs-Grade 4 |
1.931700E-02 |
| Grade 2-vs-Grade 3 |
3.567800E-04 |
| Grade 2-vs-Grade 4 |
2.276400E-01 |
| Grade 3-vs-Grade 4 |
1.878840E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
9.867800E-01 |
| Normal-vs-ccB subtype |
2.305500E-02 |
| ccA subtype-vs-ccB subtype |
1.243520E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.568500E-02 |
| Normal-vs-N1 |
8.225400E-01 |
| N0-vs-N1 |
3.221400E-01 |
|
|
